Viemed Healthcare (VMD) Return on Capital Employed (2018 - 2026)

Viemed Healthcare has reported Return on Capital Employed for 9 years, with the latest figure at 14.85% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 110.0% year-over-year to 14.85%; the trailing twelve-month figure through Mar 2026 stood at 14.85% (up 110.0% YoY), and the FY2025 full-year result was 15.61%, up 169.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 14.85%, up from 14.37% in the prior quarter.
• The five-year high for Return on Capital Employed was 14.85% in Q1 2026, with the low at 8.15% in Q1 2023.
• Historically, Return on Capital Employed has averaged 11.92% across 5 years, with a median of 11.97% in 2024.
• Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 1344 bps — and 2023, when it surged 364 bps.
• Viemed Healthcare's Return on Capital Employed stood at 8.3% in 2022, then surged by 44 bps to 11.94% in 2023, then increased by 10 bps to 13.16% in 2024, then climbed by 9 bps to 14.37% in 2025, then rose by 3 bps to 14.85% in 2026.
• The last three Return on Capital Employed figures came in at 14.85% (Q1 2026), 14.37% (Q4 2025), and 14.09% (Q3 2025), per Business Quant data.